Segments
-
Pharmaceutical
-
Consumer Health
-
MedTech
-
Public Health & Government
-
Payer & Provider
Pharmaceutical (Global page)
Bringing data science and human science together to advance human health and support the pharmaceutical industry from clinical trials to commercialization.
Learn More
Consumer Health
Connecting with powerful, evidence-based market insights to drive agile thinking, uncover growth potential, and gain competitive advantage in this fast-moving consumer health market.
LEARN MORE
MedTech
Empowering to orchestrate operations across the entire product lifecycle, from concept-to-market, providing quality control, regulatory, safety and compliance solutions along the way.
Learn more
Public Health & Government
Working across the health system to address key barriers to deliver high-quality, cost-effective care while improving health outcomes using our data-driven and population-centric solutions.
LEARN MORE
Payer & Provider
Delivering a wide range of consulting and technology solutions to support healthcare stakeholders to drive operational efficiency, enhance quality of patient care, and improve systemic outcomes.
learn moreHealthcare Provider Solutions
Solutions
-
Research & Development
-
Real World Evidence
-
Information Insights
-
Market Research
-
Strategy Consulting
-
Contract Sales & Medical Solutions
-
Patient Solutions
-
AI, Digital & Technology Solutions
Research & Development (Global page)
Clinical development enabled by Connected Intelligence™ which combines data and analytics with deep therapeutic and operational expertise to improve efficiency, enhance precision, and bring therapies to patients faster.
Learn More
Real World Evidence
Harness the power of real-world data and insights to demonstrate value-driven evidence and outcomes to meet stakeholder needs across the healthcare ecosystem and to propel healthcare forward.
LEARN MORE
Information Insights
Pharmaceutical market data and information assets that provide actionable data points to help organizations make intelligent connections and drive healthcare forward.
LEARN MORE
Market Research
Primary Intelligence integrates purpose-built and syndicated research solutions with our wide range of data assets, research methodologies, advanced analytics, and deep domain expertise, generating quality insights for our clients.
LEARN MORE
Strategy Consulting
Trusted advisor and partner to global healthcare organisations, solving the most significant business challenges through extensive healthcare expertise.
LEARN MORERelated Solutions
Contract Sales & Medical Solutions (Global page)
Optimize commercial success by leveraging our comprehensive outsourced expertise to accelerate time-to-market.
LEARN MORE
Patient Solutions (Global page)
A single window solution provider to support pharmaco’s design, deploy technology and services that help increase access to medicine and improve treatment adherence.
LEARN MORE
AI, Digital & Technology Solutions
Connected Intelligence™, digital insights, data analytics and advanced technology to power smarter decision-making to enable better patient outcomes and improved business results.
LEARN MOREOur Latest Whitepapers
Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreBlogs, Case Studies & Podcasts
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights
Our Latest White Paper
"Unlocking Pharmaceutical Potential: The Growing Role of Thai Clinics
Read more
Career Opportunities
Improving human health needs innovative thinkers. Unleash your potential with us.
Search JobsIndustry Analyst Reports
Discover how industry experts recognize IQVIA's impact across the Asia Pacific region.
LEARN MORE
Case Study
Accelerating Approval of Next-Generation Oncology Treatments for Emerging Biopharma in JAPAC
IQVIA's tailored framework and depth of expertise helped an EBP navigate the complex regulatory landscape and approval process for a novel oncology treatment, enhancing the chances of market readiness.
Nov 05, 2024
An emerging biopharma (EBP) company focusing on theranostic development partnered with IQVIA to help accelerate its market approval process. The company sought IQVIA's expertise to navigate the complexities of the regulatory landscape and FDA requirements for Phase 1 study design.
Discover how IQVIA's approach, combining advanced technology with expert insights, provided tailored strategies that supported the EBP in effectively navigating the approval process. Read the case study now.
You may also be interested in
Case Study
Enhancing Clinical Development Plan and Regulatory Support for Small Emerging Biopharma in Neuroma Therapy
Integrating IQVIA's market analysis and regulatory expertise to facilitate informed decision-making and streamlined interactions with the FDA.
Case Study
Validating Oncology Drug Indication for Approval with a Mid-sized Emerging Biopharma
How IQVIA's clinical data expertise sets the course in helping to accelerate oncology drug indication identification and prioritization for an emerging biopharma.
Infographic
Asian Market Trends in R&D 2024
Discover the R&D trends and prime opportunities in Asia Pacific, a prominent hub for the biopharma industry.
White Paper
Achieving Oncology Launch Excellence
How to navigate harsh realities in a highly fluid environment